Clinical Trial Update: PQQ for Cognitive and Negative Symptoms [NA]

View source ↗

Summary

A clinical trial is evaluating pyrroloquinoline quinone (PQQ) for cognitive and negative symptoms in schizophrenia. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PQQ (pyrroloquinoline quinone)

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia, Cognitive Symptoms | NA | Status: NOT_YET_RECRUITING